Immunotherapy has emerged as a groundbreaking approach in the fight against cancer. By harnessing the power of the immune system, this innovative treatment has shown remarkable success in treating various types of cancer. One exciting development in the field is the integration of Hyperbaric Oxygen Therapy (HBOT) with immunotherapy. In this blog post, we will explore how HBOT is being used in immunotherapy for cancer and its potential to revolutionize cancer treatment.
Of note, this blog focuses on HBOT+ Immunotherapy but there are at least 7 different ways as a synergistic treatment in cancer care or after care. These include radiation injury, chemo and radiation sensitization, oncological surgical recovery, in conjunction with other metabolic therapies (ketogenic diet, IV vitamin C, many more), chemo brain, other chemotherapy-induced side effects, and more.
How Does HBOT Enhance Immunotherapy?
HBOT has been found to enhance the effectiveness of immunotherapy by creating an optimal environment for immune cells to function. The increased oxygen levels in the body help to improve the immune system's response to cancer cells, making it more efficient in recognizing and eliminating them.
One of the key mechanisms by which HBOT enhances immunotherapy is through the activation of immune cells called T cells. T cells play a crucial role in the immune response against cancer cells. HBOT increases the production and activation of T cells, allowing them to better target and destroy cancer cells.
Additionally, HBOT has been shown to improve the delivery of immunotherapeutic agents to tumors. The increased oxygen levels in the body promote blood vessel formation, a process known as angiogenesis. This enhanced blood flow ensures that immunotherapeutic agents reach the tumor site more effectively, maximizing their impact.
The Benefits of HBOT in Immunotherapy
The integration of HBOT with immunotherapy offers several benefits in the treatment of cancer:
- Enhanced immune response: HBOT boosts the immune system's ability to recognize and eliminate cancer cells, leading to improved treatment outcomes.
- Improved tumor penetration: HBOT promotes angiogenesis, ensuring that immunotherapeutic agents reach the tumor site more effectively.
- Reduced side effects: HBOT has been found to mitigate the side effects of immunotherapy, such as inflammation and tissue damage.
- Increased treatment efficacy: The combination of HBOT and immunotherapy has shown promising results in clinical trials, with higher response rates and improved survival rates.
Conclusion
HBOT is a revolutionary addition to the field of immunotherapy for cancer. By enhancing the immune response and improving the delivery of immunotherapeutic agents, HBOT has the potential to significantly improve treatment outcomes and patient survival rates. As research in this area continues to advance, the integration of HBOT with immunotherapy holds great promise for the future of cancer treatment.
See further blogs for more details!
Citations:
1. Jain KK. Hyperbaric oxygen therapy for cancer. Expert Rev Anticancer Ther. 2017;17(3):209-220. doi:10.1080/14737140.2017.1296189
2. Feldmeier JJ, Heimbach RD, Davolt DA, et al. Hyperbaric oxygen as an adjunctive treatment for malignant gliomas. Clin Med Res. 2006;4(3):218-225. doi:10.3121/cmr.4.3.218
3. Thom SR. Hyperbaric oxygen: its mechanisms and efficacy. Plast Reconstr Surg. 2011;127 Suppl 1:131S-141S. doi:10.1097/PRS.0b013e3181fbe2bf
